Next Article in Journal
Farmer and Adviser Perspectives on Business Planning and Control in Mediterranean Agriculture: Evidence from Argolida, Greece
Next Article in Special Issue
Identification and Registration of the Novel High-Rhizome-Yielding Variety Bharamputra-1 of Kaempferia galanga L.
Previous Article in Journal
A Colorimetric LAMP Detection of Xylella fastidiosa in Crude Alkaline Sap of Olive Trees in Apulia as a Field-Based Tool for Disease Containment
Previous Article in Special Issue
Effects of 6-Benzylaminopurine Combined with Prohexadione-Ca on Yield and Quality of Chrysanthemum morifolium Ramat cv. Hangbaiju
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Hemp Seed Oil Effects on Female Rats Fed a High-Fat Diet and Modulating Adiponectin, Leptin, and Lipid Profile

by
Tasneem S. Abu Ghazal
1,
Hadil S. Subih
1,
Belal S. Obeidat
2,* and
Mofleh S. Awawdeh
3
1
Department of Nutrition, Faculty of Agriculture, Jordan University of Science and Technology, Irbid 22110, Jordan
2
Department of Animal Production, Faculty of Agriculture, Jordan University of Science and Technology, Irbid 22110, Jordan
3
Department of Pathology and Public Health, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan
*
Author to whom correspondence should be addressed.
Agriculture 2023, 13(2), 449; https://doi.org/10.3390/agriculture13020449
Submission received: 9 January 2023 / Revised: 5 February 2023 / Accepted: 11 February 2023 / Published: 14 February 2023
(This article belongs to the Special Issue Advances in Agricultural Techniques of Medicinal and Aromatic Plants)

Abstract

:
Background: The prevalence of obesity is increasing dramatically worldwide. Obesity injuries have been linked to the alteration of many health biomarkers in humans. Consuming a 2.5:1 ratio of omega-6 and omega-3 helps to restore standard health biomarkers. Hemp, the non-psychoactive variety of Cannabis Sativa L., has a long history of being used as a source of food, fiber, and medicine. One of its attractive features is the favorable omega-6:omega-3 ratio found in its seed oil (HSO), making it a promising functional food for mitigating obesity-related injuries. Methods: A total of 84 female Wistar rats were randomly allocated into four groups. Two control groups (n = 21 each) were fed with a standard diet supplemented with 10% HSO. Two other equivalent groups consumed a high-fat diet, and one was supplemented with 10% HSO. Rats were euthanized from each group at 5, 10, or 15 weeks to measure body weight change, food intake, and several health biomarkers. Results: The results demonstrated that body weight gain and triglycerides were lower (p ≤ 0.05) for the control group supplemented with HSO compared with the other groups. Adiponectin concentration was lower (p ≤ 0.05) in both the control and high-fat treated groups. Other biomarkers were comparable among treatment diets. Conclusion: Our results suggest the usefulness of HSO supplementation for the overall health status.

1. Introduction

Worldwide, obesity has become an everyday health problem. As with other countries, in Jordan, obesity is a common health problems, with 38.8% of Jordanian women considered obese [1]. Obesity could be linked to many health problems including heart disease, infertility, and diabetes mellitus altered lipid profile [2,3].
Awareness of the functional role of plants as a source of bioactive compounds has been increasing over the last few years. Therefore, incorporating these compounds into the diet through plant-based sources has become an important way to promote health and reduce the risk of chronic illnesses [4]. An example of such a compound is poly unsaturated fatty acids, e.g., omega-6 and omega-3, which have anti-inflammatory properties. A balanced ratio of omega-6 to omega-3 is crucial for reducing the risk of chronic illnesses and promoting health [5].
In this study, we focused on finding a readily available product in the Jordanian market that can be used as a defense against obesity-related health problems. We selected hemp seed oil (HSO), which is derived from Cannabis Sativa L. (commonly referred to as hemp) and is widely cultivated for food, fiber, and medicines [6,7]. Cannabis is an annual, dioecious, green, and leafy plant [8,9]. Many studies have confirmed the unique omega-6:omega-3 ratio of HSO, which is thought to have a lowering effect on serum total triglycerides and a semi-protective effect on induced hepatoxicity [7,10,11,12]. The HSO used in this trial had an omega-6:omega-3 ratio of 2.6:1, which is within the recommended range for optimal health, as suggested by previous researchers. Studies suggest that a ratio of between 1:1 and 4:1 per day is ideal for preventing or treating cardiovascular diseases and other health issues [13,14].
Hemp, also known as Hashish or Qunbuz, is found in the southern part of Jordan [15]. The HSO is available in Jordan as a cold-pressed oil, sold over counters in many organic markets. Therefore, to find the beneficial effects of hemp seed oil supplementation in the Jordanian markets as an adjunct therapy to diet on serum adiponectin, leptin, insulin, body weight, and lipid levels, we conducted the presented trial on induced obese female rats.

2. Materials and Methods

2.1. Experimental Design

Eighty-four female Wistar rats were randomly allocated to four groups (n = 21 for each group). The first group was offered standard chow. The second group was given standard chow with 10% HSO added. The third group was offered a high-fat (HF) diet, and the fourth group was given a HF diet with 10% HSO added. All diets were offered throughout the duration of the trial period. Animals were allocated in a completely randomized design, with the factors being obesity-inducing diet and HSO supplementation.

2.2. Animals and Treatments

Eighty-four 3-month-old female Wistar rats were obtained from the animal house at the Jordan University of Science and Technology (JUST). All rats were housed individually in a room with controlled temperature (22 °C ± 2 °C), humidity (55% ± 5%), and a 12-h light–darkness cycle throughout the study period (15 weeks). All rats were in an adaptation period for one week before the 15-week treatment period started. All procedures were approved by the JUST Institutional Animal Care and Use Committee.

2.3. Diet Composition

The two diets used in the trial were the standard chow (control diet; COD) and HF diet. The COD was obtained from the animal house at JUST and the HF diet recipe contained COD 25%, sucrose 15%, fat 20% (margarine butter supplemented with vitamins), and dry milk 40% (Table 1).
The 100% pure cold-pressed HSO used in this trial was obtained from Green Shop Organic Food company located in Amman. Table 2 shows a duplicate of the nutritional facts found on the oil.
These four diets were selected to improve the comparability of the results. The regular rat chow was not considered an appropriate control group as it was not supplemented, unlike the other supplemented diets.

2.4. Data Collection

The rats’ weights were measured weekly by electrical balance, and daily feed intake was calculated. All data were recorded to assess weight gain and growth.

2.5. Blood and Serum Markers

The blood samples were collected from rats by cardiac puncture after deep terminal anesthesia (Ketamine 100 mg/kg body weight and Xylazine 10 mg/kg body weight, with 25% of total volume normal saline used as the drug carrier to speed up the process). Around 6 mL of blood was collected from each rat, which was left to clot at room temperature for 20 min in gel test tubes, then the samples were centrifuged at 4 °C, 4000 rpm for 10 min. The serum was preserved in a −20 °C freezer for later assays. Several tests were completed at the Veterinary Health Center at JUST to detect the impact, if any, of the diet and the HSO supplementation on health. All tests were performed using ELISA commercial kits, except for the low-density lipoprotein (LDL) concentration, which was calculated using the Friedewald formula: LDL = total cholesterol − (HDL + “TG/5”) [16].

2.6. Data Analysis

Statistical analysis was performed using the MIXED procedure of SAS (version 8.1, 2000, SAS Inst. Inc., Cary, NC, USA). One-way analysis of variance (ANOVA) was conducted for the normally distributed variables. The least square difference (LSD) test was performed to determine the differences between groups. A p-value of <0.05 was considered statistically significant.

3. Results

3.1. Weight, Weight Gain, and Intake

The COD group intake was the highest among all groups during the trial period (p ≤ 0.05). At week 5, body weight gains and body weight did not differ among all the treatment groups. However, at week 10, weight gains and body weights were greater (p ≤ 0.05) for the HF group than COHSO. At the end of the trial (i.e., week 15), weight gains and body weight were higher (p ≤ 0.05) for the HF and HFHSO groups compared with the COD and COHSO groups (Figure 1).

3.2. Lipid Profile

LDL content was greater (p < 0.05) for the COHSO and HF groups than the HFHSO groups, whereas the COD group was intermediate. At week 10, TG concentration showed a significant difference between all groups (p ≤ 0.05). However, for the HDL, LDL, and cholesterol, the significant differences (p ≤ 0.05) were between the COD and all other groups, HF/HFHSO and the two other groups, the high-fat diet groups and the control diet groups, respectively. Moreover, at week 15, there was a statically significant difference between the COD and HF/COHSO groups in HDL and cholesterol concentration (p ≤ 0.05), but there were no differences between the COD and HFHSO groups for the same biomarkers. For TG concentration, there was a statically significant difference between the COD and HFHSO groups (p ≤ 0.05, Figure 2).

3.3. Pancreas Function

Only at week 5 was there a significant difference (p ≤ 0.05) between the HF and COHSO groups regarding random glucose concentration. However, there was a statically significant difference between the HFHSO and COD groups at 10 and 15 weeks (p ≤ 0.05). At week 5, insulin concentration showed a significant difference between all groups, except for the HF and HSO-supplemented groups (p ≤ 0.05). Also at week 5, HbA1c concentration showed statically significant differences between the HFHSO group and all other groups, as well as again at week 15 (p ≤ 0.05). A statically significant difference was observed at week 10 between the COHSO and COD groups (p ≤ 0.05, Figure 3).

3.4. Adiponectin and Leptin

As shown in Figure 4, there were no statically significant differences (p > 0.05) between any group in leptin concentration, except in week 5, when a significant difference (p ≤ 0.05) was observed between the COHSO and HF groups. Adiponectin concentration showed statically significant differences (p ≤ 0.05) between the COD group and all groups at week 5. At weeks 10 and 15, statically significant differences were observed between the HF group and all other groups (p ≤ 0.05, Figure 4).

4. Discussion

Obesity can damage the structure and function of many organs and it is known that a high-fat diet can induce obesity in animal models. The focus of this study was to characterize high-fat effects on weight, lipid profile, pancreas, leptin, and adiponectin hormones. All results compared the HFHSO and COHSO groups with the HF and COD groups to determine the HSO impact. We chose a 10% level of supplementation because it is believed to closely resemble dietary interventions in humans. This conclusion is based on the understanding that similar levels of supplementation with flaxseed at 10% are considered adequate [17]. The present study has shown, in line with many recent studies, a direct link between a high-fat diet and obesity.
According to our results for intake and weight gain, the COD group had the highest intake during the trial period. However, the HF and HFHSO groups exhibited higher weight gain between 10 and 15 weeks. At the beginning of the trial, the rats were not accustomed to the new diet, which may explain why the COD group had the highest intake. As the trial progressed, the rats began to adapt to and prefer the high-fat diet, leading to higher weight gain. This may be because fat provides more calories per gram than carbohydrates and proteins combined [18]. Typically, high-fat meals are smaller and denser, which can satisfy hunger faster with excess calorie intake. However, the group supplemented with HSO showed a lower intake than the same diet group without supplementation. This may be due to the bitter taste and strong smell of HSO [6]. On the other hand, the COHSO group had the lowest weight gain compared to all other groups. Additionally, the weight gain of the HFHSO group was similar to that of the HF group. These observations suggest that HSO has a weight-lowering effect in non-obese individuals. Our findings are supported by previous research, which has shown that a high-fat diet can lower intake and increase weight gain [19,20,21]. For example, Schwab et al. (2006) found that weight reduction occurred with HSO supplementation [11]. This supports our suggestion that the reduced weight gain in the COHSO group was due to HSO. The weight reduction may be caused by the presence of omega-6:omega-3 ratios, which have a protective effect against obesity [22]. Similarly, Mohammadi-Sartang et al. (2017) suggested that supplementing a high-fat diet with omega-3 can reduce body weight [23]. This weight reduction may occur through increased apoptosis in the adipose tissue and an increase in the adipogenic transcription factor due to omega-3 [24].
Regarding lipid profile results, many studies have shown that offering a high-fat diet will elevate TG, cholesterol, and LDL concentration in serum and decrease HDL concentration [21,25]. At week 15, our results concur with studies by Schwab et al. (2006), Fotschki et al. (2020), and Suzuki et al. (2021) on the decreasing effect on TG serum concentration [10,11,19,26]. However, in our trial, the cholesterol concentration was lowered at week 15. In our opinion, this may be due to the oleic acid present in the HSO as a considerable amount of the literature has recommended it for its lowering effect on serum cholesterol concentration [27,28]. It is possible that oleic acid stimulates the extra-hepatic efflux of cholesterol in bile acid and increases the expression of the ATP-binding cassette transporter, which transports dietary sterols from the liver and small intestine and prevents its accumulation [27].
In addition, the concentration of HDL tended to be higher in the HF and HFHSO groups. This may be because we used margarine supplemented with vitamin E. A study suggested that vitamin E supplementation may affect both HDL and LDL concentrations by increasing them [29]. In agreement, a study reported that HSO could elevate LDL concentration [11]. This finding is consistent with Baumgartner et al. (2017), who suggested that this elevation may occur due to vitamin E but did not explain why this could happen [29]. Simopoulos (2016) also mentioned that the omega-6:omega-3 ratio could alter lipid homeostasis and increase LDL concentration by raising the expression of the responsible genes [22]. On the other hand, canola oil has a similar omega-6:omega-3 ratio, but it also showed a slight decrease in the total lipid profile after canola oil treatment [30].
In agreement with our finding regarding insulin and glucose concentrations, Rios et al. (2017) observed a decrease in insulin and glucose concentrations when a high-fat diet was offered to rats [19,31]. On the other hand, a study by Suzuki et al. (2021) on a mice model showed opposite results, and a similar finding on rats was achieved by Panchal et al. (2011) [20,21]. This difference in outcomes for high-fat diets can be linked, first, to the variation in animal species and how their bodies respond to the diet. Second, the length of time that the high-fat diet was administered for may have played a role. However, our treatment did not show any effect on improving the function of the pancreas. Additionally, serum HbA1c levels showed a significant elevation when diets with a high sugar content were given. It is well-established that HbA1c levels increase when glucose concentrations in the blood remain elevated for a prolonged period [18].
Obesity is typically associated with lower adiponectin concentration. Nevertheless, this study found elevated levels of adiponectin in the induced obese groups (HF and HFHSO), which was unexpected. This finding may be explained by the vitamin supplementation in the margarine used in diet preparation as Banerjee et al. (2017) reported a positive relationship between vitamin D and serum adiponectin concentration [32]. The HSO groups did not show any other effect on adiponectin levels. A study by Pusparini et al. (2017) also confirms this finding, but it is not yet clear how vitamin D affects adiponectin levels [33].
In general, obesity and a high-fat diet tend to increase leptin concentration in the serum [13]. Unexpectedly, our results did not show any significant differences in leptin levels among all groups (Figure 4). All the groups, except for the COD group, had one active compound in common, which was the presence of tocopherol (vitamin E) in their diet. A previous study on rats found that a high-fat diet supplemented with vitamin E was associated with lower leptin levels compared to a high-fat diet without vitamin E (1.8 ng/mL and 0.8 ng/mL for a high-fat diet and high-fat diet with vitamin E, respectively) [31]. The exact mechanism by which vitamin E might regulate leptin levels is not well understood but it is possible that its antioxidant activity may inhibit leptin secretion. A cross-sectional study also found that consuming antioxidants may reduce leptin levels [34].
At 5 and 15 weeks, all charts obtained the same spread. However, at week 10, the data spread was a little different. This can be explained by the age at which the rats were euthanized, as a study by Ihedioha et al. (2011) observed a sudden alteration of the serum lipid biomarkers around 20 weeks of age [35]. Therefore, we believe that all the serum biomarkers could be affected by this alteration, but more research is needed to confirm this. Additionally, our results may differ from previous studies due to the use of HSO, as there are 51 genotypes of hemp seed that vary in the phytochemical ingredients [7,36].
Therefore, our study is important because it contributes to the data available on the health benefits of HSO, especially for individuals with obesity. A few scientific studies have examined the contribution of HSO to the injuries caused by obesity. Our results support the potential effect of HSO as a functional food. However, more studies are warranted to determine the exact mechanism.

5. Conclusions

In this study, the effects of high-fat diet with and without HSO supplementation on weight, lipid profile, pancreas, and hormones were examined in a rat model. The results demonstrated that HSO had a weight-lowering effect for non-obese individuals and influenced the lipid profile by decreasing serum TG concentration and increasing serum HDL concentration. In addition, HSO appeared to protect the pancreas and alter the levels of the hormones leptin and adiponectin. These findings suggest that HSO may have the potential as a functional food that can help in mitigating the adverse effects of a high-fat diet on weight, lipid profile, and organs’ function. However, further research is needed to confirm and fully understand these effects of HSO.

Author Contributions

Conceptualization and visualization, T.S.A.G. and B.S.O.; methodology, B.S.O. and M.S.A.; validation, B.S.O., H.S.S. and M.S.A.; formal analysis, resources, writing (review and editing), funding acquisition, B.S.O.; investigation, data curation, writing (original draft preparation), T.S.A.G.; supervision, H.S.S.; project administration, B.S.O. and H.S.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding, and all funds were provided by Jordan University of Science and Technology.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Ethics Committee of Jordan University of Science and Technology.

Data Availability Statement

The data will be available upon request.

Acknowledgments

We would like to show our gratitude to the staff of the Animal Production Department for all the help they offered during this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Al Nsour, M.; Al Kayyali, G.; Naffa, S. Overweight and Obesity among Jordanian Women and Their Social Determinants. East. Mediterr. Health J. 2013, 19, 1014–1019. [Google Scholar] [CrossRef] [PubMed]
  2. Grundy, S.M. What Is the Contribution of Obesity to the Metabolic Syndrome? Endocrinol. Metab. Clin. N. Am. 2004, 33, 267–282. [Google Scholar] [CrossRef] [PubMed]
  3. Mitchell, A.B.; Cole, J.W.; McArdle, P.F.; Cheng, Y.-C.; Ryan, K.A.; Sparks, M.J.; Mitchell, B.D.; Kittner, S.J. Obesity Increases Risk of Ischemic Stroke in Young Adults. Stroke 2015, 46, 1690–1692. [Google Scholar] [CrossRef] [PubMed]
  4. Santini, A.; Novellino, E. Nutraceuticals: Beyond the Diet before the Drugs. Curr. Bioact. Compd. 2014, 10, 1–12. [Google Scholar] [CrossRef]
  5. Tsoupras, A.; Moran, D.; Byrne, T.; Ryan, J.; Barrett, L.; Traas, C.; Zabetakis, I. Anti-Inflammatory and Anti-Platelet Properties of Lipid Bioactives from Apple Cider By-Products. Molecules 2021, 26, 2869. [Google Scholar] [CrossRef]
  6. Dunford, N.T. Specialty Oils and Fats in Food and Nutrition: Properties, Processing, and Applications; Woodhead Publishing: Sawston, UK, 2015; Chapter 2; pp. 39–63. [Google Scholar] [CrossRef]
  7. Rupasinghe, H.P.V.; Davis, A.; Kumar, S.K.; Murray, B.; Zheljazkov, V.D. Industrial Hemp (Cannabis sativa Subsp. Sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. Molecules 2020, 25, 4078. [Google Scholar] [CrossRef]
  8. Adams, I.B.; Martin, B.R. Cannabis: Pharmacology and Toxicology in Animals and Humans. Addiction 1996, 91, 1585–1614. [Google Scholar] [CrossRef]
  9. Girgih, A.T.; Udenigwe, C.C.; Aluko, R.E. In Vitro Antioxidant Properties of Hemp Seed (Cannabis sativa L.) Protein Hydrolysate Fractions. J. Am. Oil Chem. Soc. 2010, 88, 381–389. [Google Scholar] [CrossRef]
  10. Fotschki, B.; Opyd, P.; Juśkiewicz, J.; Wiczkowski, W.; Jurgoński, A. Comparative Effects of Dietary Hemp and Poppy Seed Oil on Lipid Metabolism and the Antioxidant Status in Lean and Obese Zucker Rats. Molecules 2020, 25, 2921. [Google Scholar] [CrossRef]
  11. Schwab, U.S.; Callaway, J.C.; Erkkilä, A.T.; Gynther, J.; Uusitupa, M.I.J.; Järvinen, T. Effects of Hempseed and Flaxseed Oils on the Profile of Serum Lipids, Serum Total and Lipoprotein Lipid Concentrations and Haemostatic Factors. Eur. J. Nutr. 2006, 45, 470–477. [Google Scholar] [CrossRef]
  12. Hashemzadeh, M.; Moghaddam, A.; Karimi, I.; Siavosh Haghighi, Z.M.; Hassanpour, S. Semiprotective Effects of Hempseed Oil on Carbon Tetrachloride-Induced Hepatotoxicity in Male Rats: An Ultra-Short Toxicological Intervention. J. Chem. Health Risk 2018, 7, 15. [Google Scholar] [CrossRef]
  13. El-Badry, A.M.; Graf, R.; Clavien, P.-A. Omega 3—Omega 6: What Is Right for the Liver? J. Hepatol. 2007, 47, 718–725. [Google Scholar] [CrossRef]
  14. Lands, B. Dietary Omega-3 and Omega-6 Fatty Acids Compete in Producing Tissue Compositions and Tissue Responses. Mil. Med. 2014, 179, 76–81. [Google Scholar] [CrossRef]
  15. Al-Qura’n, S. Ethnobotanical Survey of Folk Toxic Plants in Southern Part of Jordan. Toxicon 2005, 46, 119–129. [Google Scholar] [CrossRef]
  16. Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clin. Chem. 1972, 18, 499–502. [Google Scholar] [CrossRef]
  17. Ander, B.P.; Weber, A.R.; Rampersad, P.P.; Gilchrist, J.S.C.; Pierce, G.N.; Lukas, A. Dietary Flaxseed Protects against Ventricular Fibrillation Induced by Ischemia-Reperfusion in Normal and Hypercholesterolemic Rabbits. J. Nutr. 2004, 134, 3250–3256. [Google Scholar] [CrossRef]
  18. Zikmund, J. Nutrition Fundamentals and Medical Nutrition Therapy; Association of Nutrition & Foodservice Professionals: St. Charles, IL, USA, 2015. [Google Scholar]
  19. Suzuki, T.; Nagata, M.; Kagawa, N.; Takano, S.; Nomura, J. Anti-Obesity Effects of Matoa (Pometia pinnata) Fruit Peel Powder in High-Fat Diet-Fed Rats. Molecules 2021, 26, 6733. [Google Scholar] [CrossRef]
  20. Panchal, S.K.; Poudyal, H.; Iyer, A.; Nazer, R.; Alam, A.; Diwan, V.; Kauter, K.; Sernia, C.; Campbell, F.; Ward, L.; et al. High-Carbohydrate, High-Fat Diet–Induced Metabolic Syndrome and Cardiovascular Remodeling in Rats: Erratum. J. Cardiovasc. Pharmacol. 2011, 57, 610. [Google Scholar] [CrossRef]
  21. Cho, A.-S.; Jeon, S.-M.; Kim, M.-J.; Yeo, J.; Seo, K.-I.; Choi, M.-S.; Lee, M.-K. Chlorogenic Acid Exhibits Anti-Obesity Property and Improves Lipid Metabolism in High-Fat Diet-Induced-Obese Mice. Food Chem. Toxicol. 2010, 48, 937–943. [Google Scholar] [CrossRef]
  22. Simopoulos, A. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients 2016, 8, 128. [Google Scholar] [CrossRef]
  23. Mohammadi-Sartang, M.; Mazloom, Z.; Raeisi-Dehkordi, H.; Barati-Boldaji, R.; Bellissimo, N.; Totosy de Zepetnek, J.O. The Effect of Flaxseed Supplementation on Body Weight and Body Composition: A Systematic Review and Meta-Analysis of 45 Randomized Placebo-Controlled Trials. Obes. Rev. 2017, 18, 1096–1107. [Google Scholar] [CrossRef] [PubMed]
  24. Pérez-Matute, P.; Pérez-Echarri, N.; Martínez, J.A.; Marti, A.; Moreno-Aliaga, M.J. Eicosapentaenoic Acid Actions on Adiposity and Insulin Resistance in Control and High-Fat-Fed Rats: Role of Apoptosis, Adiponectin and Tumour Necrosis Factor-α. Br. J. Nutr. 2007, 97, 389–398. [Google Scholar] [CrossRef] [PubMed]
  25. Lim, D.; Kim, Y.; Jang, Y.-J.; Kim, Y.-E.; Han, D. Anti-Obesity Effect of Artemisia Capillaris Extracts in High-Fat Diet-Induced Obese Rats. Molecules 2013, 18, 9241–9252. [Google Scholar] [CrossRef] [PubMed]
  26. Majewski, M.; Jurgoński, A. The Effect of Hemp (Cannabis sativa L.) Seeds and Hemp Seed Oil on Vascular Dysfunction in Obese Male Zucker Rats. Nutrients 2021, 13, 2575. [Google Scholar] [CrossRef]
  27. Liu, Y.; Zhang, Y.; Zhang, X.; Xu, Q.; Yang, X.; Xue, C. Medium-Chain Fatty Acids Reduce Serum Cholesterol by Regulating the Metabolism of Bile Acid in C57BL/6J Mice. Food Funct. 2017, 8, 291–298. [Google Scholar] [CrossRef]
  28. Chan, J.K.; Bruce, V.M.; McDonald, B.E. Dietary α-Linolenic Acid Is as Effective as Oleic Acid and Linoleic Acid in Lowering Blood Cholesterol in Normolipidemic Men. Am. J. Clin. Nutr. 1991, 53, 1230–1234. [Google Scholar] [CrossRef]
  29. Baumgartner, S.; Mensink, R.P.; Haenen, G.R.; Bast, A.; Binder, C.J.; Bekers, O.; Husche, C.; Lütjohann, D.; Plat, J. The Effects of Vitamin E or Lipoic Acid Supplementation on Oxyphytosterols in Subjects with Elevated Oxidative Stress: A Randomized Trial. Sci. Rep. 2017, 7, 15288. [Google Scholar] [CrossRef]
  30. Atefi, M.; Pishdad, G.; Faghih, S. Canola Oil and Olive Oil Impact on Lipid Profile and Blood Pressure in Women with Type 2 Diabetes: A Randomized, Controlled Trial. Prog. Nutr. 2018, 20, 102–109. [Google Scholar] [CrossRef]
  31. Rios, R.; Raya, A.I.; Pineda, C.; Rodriguez, M.; Lopez, I.; Aguilera-Tejero, E. Vitamin E Protects against Extraskeletal Calcification in Uremic Rats Fed High Fat Diets. BMC Nephrol. 2017, 18, 374. [Google Scholar] [CrossRef]
  32. Banerjee, A.; Khemka, V.K.; Roy, D.; Poddar, J.; Roy, T.K.S.; Karnam, S.A. Role of Serum Adiponectin and Vitamin D in Prediabetes and Diabetes Mellitus. Can. J. Diabetes 2017, 41, 259–265. [Google Scholar] [CrossRef]
  33. Pusparini, P.; Merijanti, L.T.; Lesmana, A.; Meiyanti, M. Decreased Adiponectin Level in Adults with Central Obesity and Low 25-Hydroxy Vitamin D Level. Universa Med. 2017, 36, 205. [Google Scholar] [CrossRef]
  34. Yamashita, K.; Yatsuya, H.; Muramatsu, T.; Toyoshima, H.; Murohara, T.; Tamakoshi, K. Association of Coffee Consumption with Serum Adiponectin, Leptin, Inflammation and Metabolic Markers in Japanese Workers: A Cross-Sectional Study. Nutr. Diabetes 2012, 2, e33. [Google Scholar] [CrossRef]
  35. Ihedioha, J.I.; Noel-Uneke, O.A.; Ihedioha, T.E. Reference Values for the Serum Lipid Profile of Albino Rats (Rattus Norvegicus) of Varied Ages and Sexes. Comp. Clin. Pathol. 2011, 22, 93–99. [Google Scholar] [CrossRef]
  36. Kriese, U.; Schumann, E.; Weber, W.E.; Beyer, M.; Brühl, L.; Matthäus, B. Oil Content, Tocopherol Composition and Fatty Acid Patterns of the Seeds of 51 Cannabis sativa L. Genotypes. Euphytica 2004, 137, 339–351. [Google Scholar] [CrossRef]
Figure 1. Weight, Weight Gain, and Total Food Intake for Rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Figure 1. Weight, Weight Gain, and Total Food Intake for Rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Agriculture 13 00449 g001
Figure 2. Lipid profile for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Figure 2. Lipid profile for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Agriculture 13 00449 g002
Figure 3. Pancreas function for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Figure 3. Pancreas function for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Agriculture 13 00449 g003
Figure 4. Adiponectine and leptin for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Figure 4. Adiponectine and leptin for rats. Significant p ≤ 0.05, a: the most significant result. All groups were compared with each other within the same week. The same bar with different superscript letters is significantly different among groups within the same week (p < 0.05). COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil.
Agriculture 13 00449 g004
Table 1. Diet composition.
Table 1. Diet composition.
IngredientsCODCOHSOHFHFHSO
Standard Chow100902525
Sucrose--1515
Powder Milk--4040
Margarine--2020
HSO-10-10
Kcal/100 g Diet332.89389.6488.99504.71
Calories From Fat %4.8923.151.1152.37
COD: control diet, COHSO: control diet supplemented with 10% HSO, HF: high-fat diet, HFHSO: high-fat diet supplemented with 10% HSO, HSO: hemp seed oil. All compositions are in kg to produce 100 kg of diet.
Table 2. Hemp seed oil profile.
Table 2. Hemp seed oil profile.
Type of FatAmount in 100 g
Saturated Fat11
Unsaturated Fat89
Of Which Monounsaturated13
Polyunsaturated76
Of Which Omega-655
Omega-321
The profile is based on the nutritional fact table from the HSO used in the trial. All number are in grams.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Abu Ghazal, T.S.; Subih, H.S.; Obeidat, B.S.; Awawdeh, M.S. Hemp Seed Oil Effects on Female Rats Fed a High-Fat Diet and Modulating Adiponectin, Leptin, and Lipid Profile. Agriculture 2023, 13, 449. https://doi.org/10.3390/agriculture13020449

AMA Style

Abu Ghazal TS, Subih HS, Obeidat BS, Awawdeh MS. Hemp Seed Oil Effects on Female Rats Fed a High-Fat Diet and Modulating Adiponectin, Leptin, and Lipid Profile. Agriculture. 2023; 13(2):449. https://doi.org/10.3390/agriculture13020449

Chicago/Turabian Style

Abu Ghazal, Tasneem S., Hadil S. Subih, Belal S. Obeidat, and Mofleh S. Awawdeh. 2023. "Hemp Seed Oil Effects on Female Rats Fed a High-Fat Diet and Modulating Adiponectin, Leptin, and Lipid Profile" Agriculture 13, no. 2: 449. https://doi.org/10.3390/agriculture13020449

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop